BCLI Brainstorm Cell Therapeutics Inc

Brainstorm Cell Therapeutics Inc is a biotechnology company. The Company develops novel adult stem cell therapies for debilitating neurodegenerative disorders such as ALS, MS, and PD among others.

$3.88
As of 06/24/2021     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  10/31/2003
Outstanding shares:  36,318,561
Average volume:  353,300
Market cap:   $136,557,789
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    10501E201
ISIN:        US10501E2019
Sedol:      BQQFDM3

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   3.83
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%